]ME effect of FK506 and cyclosporin A (CsA) on the production of interleukin 6 
(TNF00 and interleukin 1 (IL-I) was slightly suppressed by FK506 and CsA at the concentrations tested. Moreover, pretreatment of monocytes with FK506 and CsA had a significant enhancing effect on LPS-induced IL-6 production, while treatment with FK506 or CsA after LPS stimulation had no effects on IL-6 production, suggesting that the enhancing effect of each drug is exerted before LPS stimulation or at an early stage of the post-receptor pathway after LPS stimulation. These experiments demonstrate that FK506 and CsA can selectively enhance IL-6 production in monocytes under certain conditions in vitro and, possibly, also in vtvo. FK506 and cyclosporin A enhance IL-6 production in monocytes" a single-cell assay Introduction Cyclosporin A (CsA) is a representative immunosuppressive drug, effective in the treatment of haematologic disorders such as aplastic anaemia and pure red cell aplasia. FK506, a macrolide antibiotic obtained from Streptomyces tsukubaensis," has a powerful and selective anti-T cell effect, similar to that of CsA. Moreover, some biological roles for the two agents, distinct from T-cell immunosuppression, have been defined. [7] [8] [9] However, their effects on human monocytes are still unclear. Monocytes can produce several cytokines such as interleukin 6 (IL-6), 1 tumour necrosis factor-z (TNF00 and interleukin 1 (IL-I). Andersson et al. 11 reported these two drugs had no effect on IL-6 production in monocytes after LPS stimulation.
The present study examined whether FK506
and CsA would influence the production of (Fig. 2) . The increase of IL-6 producing monocytes was observed at drug concentrations between 0.12 nM and 1.2 l.tM (0.1 and 1 000 ng/ml) for FK506
( Fig. 2A) and between 0.83 nM and 8.3 I.tM (1 and 10 000 ng/ml) for CsA (Fig. 2B) (1 000ng/ml) and 8.3 l.tM (10 000 ng/mD, respectively (Fig. 3) . The percentage of TNF(x and IL-Iproducing monocytes was assessed every hour from 1 h to 6 h after LPS stimulation under the same conditions; FK506 and CsA had little or no effect on the production of each cytokine (data not shown).
Ethanol, which was used as the solvent, had no effect on the production of these cytokines at a 100-fold dilution. The viability of cells remained at more than 95% as assessed by trypan blue dye uptake under the experimental conditions of this study. Next, the effect of FK506 and CsA on IL-6-production was examined by stimulating monocytes with various amount of LPS (Fig. 4) . Monocytes were cultured with LPS (100 pg/ml-lO lttg/mD and 12 nM (lOng/ml) FK506, 0.83btM (1 O00ng/ml)CsA, or medium. After 4 h of culture, the percentage of IL-6-producing cells was assessed. The percentage of IL-6-producing monocytes was about the same (34.6%-36.6%) when stimulated with LPS alone at doses ranging between 100 pg/ml and 10 ng/ml. However, it increased when stimulated with LPS at the concentrations of 10 ng/ml-lO btg/ml, in a dose dependent manner. As shown in Fig. 4, both FK506 and CsA increased the percentage of IL-6-producing monocytes when stimulated with 100 pg/ml-1 l.tg/ml of LPS. At the concentration of 10 ng/ml of 
